Spiramycin/cotrimoxazole versus pyrimethamine/sulfonamide and spiramycin alone for the treatment of toxoplasmosis in pregnancy

[1]  J. Garweg,et al.  Therapy for Ocular Toxoplasmosis – The Future , 2013, Ocular immunology and inflammation.

[2]  W. Lim,et al.  Treatment of Community-Acquired Lower Respiratory Tract Infections during Pregnancy , 2012, American journal of respiratory medicine : drugs, devices, and other interventions.

[3]  D. Buonsenso,et al.  [Congenital toxoplasmosis treatment] , 2011, European review for medical and pharmacological sciences.

[4]  A. Takaćs,et al.  Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite-to-bradyzoite conversion at higher rates than fibroblasts. , 2009, International journal of medical microbiology : IJMM.

[5]  G. Maartens,et al.  Treating AIDS-associated cerebral toxoplasmosis - pyrimethamine plus sulfadiazine compared with cotrimoxazole, and outcome with adjunctive glucocorticoids. , 2007, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[6]  R. Gilbert,et al.  Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data , 2007, The Lancet.

[7]  P. d’Azevedo,et al.  Toxoplasma-IgM and IgG-avidity in single samples from areas with a high infection rate can determine the risk of mother-to-child transmission. , 2006, Revista do Instituto de Medicina Tropical de Sao Paulo.

[8]  R. Gilbert,et al.  Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: A cohort study in 13 European centres , 2005, Acta paediatrica.

[9]  G. Peyman,et al.  Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. , 2005, Ophthalmology.

[10]  A. Prusa,et al.  Determinants of response to a parent questionnaire about development and behaviour in 3 year olds: European multicentre study of congenital toxoplasmosis , 2005, BMC pediatrics.

[11]  J. Dötsch,et al.  An exceptional Albanian family with seven children presenting with dysmorphic features and mental retardation: maternal phenylketonuria , 2005, BMC pediatrics.

[12]  P. J. Irvine,et al.  Maternal serologic screening for toxoplasmosis. , 2003, Journal of midwifery & women's health.

[13]  R. Gilbert,et al.  Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii , 2003, BJOG : an international journal of obstetrics and gynaecology.

[14]  Participants are listed on page.  Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. , 2003 .

[15]  G. Holland,et al.  An update on current practices in the management of ocular toxoplasmosis. , 2002, American journal of ophthalmology.

[16]  B. Horta,et al.  The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. , 2002, American journal of ophthalmology.

[17]  A. Ades,et al.  Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. , 2001, International journal of epidemiology.

[18]  A. Ades,et al.  Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. , 2001, International journal of epidemiology.

[19]  J. Olsen,et al.  The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. , 2001, Reproductive toxicology.

[20]  R. Gilbert,et al.  Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden , 2001, Epidemiology and Infection.

[21]  R. Gilbert,et al.  Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol , 2001, Epidemiology and Infection.

[22]  E. C. Neto,et al.  High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. , 2000, International journal of epidemiology.

[23]  P. Garner,et al.  Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy , 1999, BMJ.

[24]  R. Gilbert,et al.  Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling , 1999, The Lancet.

[25]  B. Stray-Pedersen,et al.  Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. , 1999, American journal of obstetrics and gynecology.

[26]  A. Oxman,et al.  Screening for Toxoplasmosis in Pregnancy: What is the Evidence of Reducing a Health Problem? , 1996, Journal of medical screening.

[27]  R. Lynfield,et al.  Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. , 1994, The New England journal of medicine.

[28]  M. Sharpe,et al.  Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis. , 1992, Ophthalmology.

[29]  J. Klein,et al.  Infectious Diseases of the Fetus and Newborn Infant , 1983 .

[30]  R. Leeming.  CO-TRIMOXAZOLE AND PHENYLALANINE METABOLISM , 1980, The Lancet.

[31]  Miles Be,et al.  Letter: Serum-phenytoin. , 1976 .

[32]  P. Valentini,et al.  Role of spiramycin/cotrimoxazole association in the mother-to-child transmission of toxoplasmosis infection in pregnancy , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[33]  R. McLeod,et al.  Chapter 31 – Toxoplasmosis , 2006 .

[34]  G. Dutton,et al.  Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. , 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

[35]  P. Zuber,et al.  [Prevention of congenital toxoplasmosis in Europe]. , 1995, Schweizerische medizinische Wochenschrift. Supplementum.

[36]  Neonatal serologic screening and early treatment for congenital toxoplasma gondii infection , 1995 .

[37]  B. T. Nguyen,et al.  In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii. , 1975, Pathologia Europaea.